StonvexLoading…
StonvexStonvexStonvexCore line items from HYFM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $134.25M | $109.13M | $79.78M | $40.53M |
Operating Income | $-276.92M | $-37.29M | $-24.33M | $-10.99M |
Net Income | $-289.79M | $-47.64M | $-31.25M | $-14.38M |
EPS (Diluted) | $-62.35 | $-10.26 | $-6.75 | $-3.12 |
Total Assets | $123.80M | $369.68M | $389.88M | $410.56M |
Total Liabilities | $187.10M | $191.40M | $194.87M | $200.61M |
Cash & Equivalents | $6.31M | $10.65M | $10.99M | $13.73M |
Free Cash Flow OCF − CapEx | $-15.08M | $-10.78M | $-10.57M | $-12.01M |
Shares Outstanding | 4.67M | 4.67M | 4.66M | 4.62M |